HIV vaccine acceptance among heterosexual clients of a sexually transmitted diseases clinic.

Abstract

We evaluated the willingness of clients at a large urban sexually transmitted diseases (STD) clinic in the southeastern United States to participate in future trials of preventive vaccines for HIV type 1 (HIV-1). A single trained interviewer administered an oral survey instrument to STD clinic clients over a 4-week enrollment period. The participants were 167 randomly selected clients (90 men and 77 women), most of whom were young, African-American heterosexuals. Risk behaviors for HIV-1 infection were highly prevalent. Overall, 67% of clients expressed willingness to consider participation in an HIV-1 vaccine trial. By univariate analysis, prior HIV-1 testing was significantly associated with willingness to participate (P = 0.04). Multivariate analysis revealed that female gender (P = 0.05) and prior HIV-1 testing (P = 0.03) were significant predictors of willingness to participate.

• Authors: J Tello, S J Soong, B Hunter, R Meriwether, E W Hook 3rd, M J Mulligan
• Journal: The American journal of the medical sciences (Am J Med Sci) Vol. 315 Issue 1 Pg. 11-6 (Jan 1998) ISSN: 0002-9629 [Print] United States
• PMID: 9427569 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• AIDS Vaccines

Topics

• AIDS Vaccines
• Acquired Immunodeficiency Syndrome (prevention & control)
• Adult
• Black or African American
• Alabama
• Analysis of Variance
• Clinical Trials as Topic
• Community Health Services
• Female
• HIV-1
• Heterosexuality
• Humans
• Male
• Multivariate Analysis
• Patient Acceptance of Health Care
• Risk-Taking
• Sexually Transmitted Diseases
• Southeastern United States
• Surveys and Questionnaires
• Urban Population
• White People